Table 2.
Protease | Kd DRV (nM) | Relative Kd | Amino acid substitutions |
---|---|---|---|
Wild type | 0.005 | 1.0 | |
PR20† | 41.000 | 8200 | Q7K, L10F, I13V, I15V, D30N, V32I, L33F, E35D, M36I, S37N, I47V, I54L, Q58E, I62V, L63P, A71V, I84V, N88D, L89T, L90M |
P51†‡ | 37.000 | 7400 | L10I, I15V, K20R, L24I, V32I, I33F, M36I, M46L, I54M, I63P, K70Q, V82I, I84V, L89M |
PRdrv1§ | 15.000 | 3000 | L10I, M36V, M46L, I54V, I62V, L63P, A71V, V82A, I84V, L90M |
PRdrv2§ | 0.750 | 150 | T12V, I13V, I15V, K20M, V32I, L33F, K43T, I54L, K55N, I62V, L63P, A71V, I72V, G73S, V77I, V82L, I84V, L89V, L90M |
PRdrv3§ | 0.004 | 0.82 | I13V, K20R, V32I, L33F, E35D, M36I, R41K, K43T, I47V, I54M, I62V, L63V, A71V, I72T, G73S, T74P, V82L, L89V, I93L |
PRdrv4§ | 35.000 | 7000 | L10F, I13V, D30N, K45I, I50L, L63P, A71I, V77I, N88D |
PRdrv5§ | 0.370 | 74 | L10I, I13V, K14R, V32I, L33F, K43T, M46I, I47V, I54L, I62V, L63P, A71T, I72T, G73T, V77I, P79S, I84V, L90M |
PRdrv6§ | 1.800 | 360 | L10I, I13V, G16E, L33F, M36L, N37T, P39S, K45R, M46L, I54V, K55R, I62V, L63P, A71V, G73D, V82T, I84V, L89V, L90M, I93L |
Comparison of drug resistant HIV protease variants bearing multiple substitutions and the DRV binding affinity measured by isothermal titration calorimetry. Assays used different conditions, and may not be directly comparable to each other. Major mutations from Table 1 are shown in bold and underlined.
Data taken from [42].
Selected in vitro. Other mutants are from clinical isolates.
Data taken from [41].